The UK-based nanomedicine biotech, previously known as SomaServe, has closed its Series A with some significant biopharma names attached.
Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines Read More »
The UK-based nanomedicine biotech, previously known as SomaServe, has closed its Series A with some significant biopharma names attached.
At its highest dose level of 608 mg, lepodisiran reduced lipoprotein(a) levels by a median of 94% after 48 weeks.
Lilly Notches Second Cholesterol Win with RNA Silencer Read More »
When given at potentially therapeutic doses, Verve’s base editor led to strong reductions in LDL cholesterol and PCSK9 levels in patients with heterozygous familial hypercholesterolemia.
Verve’s Gene Editor Cuts Cholesterol in First-in-Human HeFH Trial Read More »
Novo Nordisk posted new data at AHA 2023 showing that its blockbuster weight loss drug could cut the risk of major cardiovascular events—including heart attack—across patient subgroups.
Novo Builds Wegovy’s Cardio Case with Much-Anticipated Data Drop Read More »
source La emoción de la ruleta en vivo ahora está disponible en línea gracias a los modernos casinos en vivo. Con dealers en vivo transmitiendo en HD, los jugadores pueden disfrutar de una experiencia de casino auténtica desde la comodidad de sus hogare …
Los Mejores Proveedores de Casinos en Vivo: Una Guía para Jugar Ruleta en Línea Read More »
Noticias de la actualidad científica y tecnológica del 13 de noviembre de 2023. …
Using ISACA’s CMMI framework, medical device manufacturers have seen significant improvements, underscoring the program’s positive influence on patient outcomes.
When discussing the gap between the status quo and safe, high-quality health care, many organizations realize that improving health equity is a moral and economic imperative as the business case for equity is well-documented.
How payers can advance health equity as part of coordinated action Read More »
Trends across technology, talent, care and operations are forcing healthcare leaders to take stock and anticipate where to focus their attention over the next three to five years.
4 ways healthcare organizations can navigate industry challenges Read More »
